Join
Live feed
·
PRReleasevia Quantisnow
BeyondSpring Inc. logo

SEED Therapeutics (SEED) Enters into Strategic Research Collaboration with Eisai Co., Ltd. to Discover and Develop Novel Molecular Glue Degraders for Neurodegeneration and Oncology Indications

ByQuantisnow·Wall Street's wire, on your screen.
BYSI· BeyondSpring Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BYSI (BeyondSpring Inc.) and more on Quantisnow.